TILRAY BRANDS Stock Price, News & Analysis

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) is a global lifestyle and consumer packaged goods company operating at the intersection of the cannabis, beverage, wellness, and entertainment industries. According to the company’s public disclosures, Tilray’s platform supports more than 40 brands across over 20 countries, with operations in Canada, the United States, Europe, Australia, and Latin America. The company’s activities span cannabis, hemp-based foods, craft beverages, and related consumer products that are positioned around social connection, wellness, and premium lifestyle experiences.

Tilray describes its mission as becoming a premium lifestyle company with a house of brands and products that inspire joy, wellness, and memorable experiences. Within cannabis, the company highlights comprehensive offerings that include adult-use and medical products across multiple markets. Through its wellness and hemp-based food lines, Tilray participates in plant-based and cannabinoid-focused categories, while its beverage business includes craft beers, premium spirits, ready-to-drink cocktails, non-alcoholic beers, and hemp-derived THC beverages, as reflected in recent product announcements and seasonal collections.

Business Segments and Brand Platform

Tilray’s public communications reference a diversified portfolio spanning cannabis, beverage, wellness, and distribution sectors. In its financial reporting, the company identifies cannabis, beverage, wellness, and distribution (including Tilray Pharma) as key revenue contributors. Cannabis activities include international medical cannabis exports, Canadian adult-use cannabis, and branded products sold under subsidiaries such as Aphria Inc. The distribution segment includes Tilray Pharma, which the company describes as a medical distribution platform.

In beverages, Tilray highlights a broad lineup of craft beer and spirits brands as well as ready-to-drink cocktails and hemp-derived THC beverages. Its holiday and Dry January guides showcase brands such as Breckenridge (whiskeys and spirits), 10 Barrel Brewing, Blue Point Brewing, Montauk Brewing, SweetWater Brewing, Terrapin Beer Co., Atwater Brewery, Widmer Brothers, and various hemp-derived THC beverage brands like Happy Flower and Fizzy Jane’s. The company also promotes non-alcoholic offerings, including non-alcoholic beers and zero-proof spirits under the Mock One brand, as part of a mindful drinking and “sober curious” positioning.

Within cannabis, Tilray’s brand portfolio includes Good Supply, Redecan, Broken Coast, Mollo, XMG, and Chowie, among others, as highlighted in its Canadian product announcements and gift guides. These brands cover categories such as pre-rolls, flower, vapes, live resin products, cannabis-infused beverages, and edibles. Tilray notes that many cannabis products in Canada are sold through its wholly owned subsidiary Aphria Inc., a licensed producer under the Cannabis Act.

Medical Cannabis and Tilray Medical

Tilray Medical is a division of Tilray Brands focused on medical cannabis healthcare. The company states that it operates in federally regulated medical cannabis markets globally and has worked with regulators, physicians, hospitals, and research institutions. Tilray reports that it offers more than 200 registered medical cannabis products across international markets for therapeutic use and has served over 500,000 registered patients globally. It also notes participation in more than 15 medical cannabis studies and clinical trials in partnership with hospitals and physicians, addressing conditions such as pediatric epilepsy, cancer-induced nausea, PTSD, pain, anxiety, essential tremors, alcohol use disorder, fibromyalgia, glioblastoma, and cannabinoids and driving performance.

Following U.S. federal cannabis rescheduling, Tilray announced the formation of Tilray Medical USA, Inc. as part of a strategic framework to advance its U.S. medical cannabis operations. The company emphasizes its existing compliance systems, scientific expertise, and governance practices developed in other regulated markets, and indicates that it plans to introduce medical-grade cannabis products in targeted therapeutic formats as regulations allow.

Geographic Footprint and Operations

Tilray states that it has operations in Canada, the United States, Europe, Australia, and Latin America. Its disclosures describe an established global footprint that supports its cannabis, beverage, wellness, and distribution activities. In Canada, the company is active in adult-use cannabis, medical cannabis, and cannabis-infused beverages, with brands such as Good Supply, Redecan, Mollo, XMG, and others available through provincial retailers and licensed online channels. In the United States, Tilray’s exposure includes beverage alcohol brands, non-alcoholic beverages, hemp-derived THC drinks, and, through Tilray Medical USA, a framework for medical cannabis expansion in line with federal rescheduling developments.

Internationally, Tilray highlights its role in medical cannabis export markets and notes that Tilray Pharma operates as a distribution platform. The company’s communications emphasize its experience in tightly regulated medical cannabis environments and its focus on quality, compliance, and patient safety in those markets.

Financial Reporting and Corporate Actions

Tilray files reports with the U.S. Securities and Exchange Commission and is listed on The Nasdaq Global Select Market under the symbol TLRY, with its common stock also trading on the Toronto Stock Exchange under the same symbol. In an 8-K filing and related press release, the company disclosed that its board of directors approved a one-for-ten reverse stock split of its common stock, effective as of December 1, 2025, with trading on a split-adjusted basis beginning December 2, 2025, under the existing symbol TLRY and a new CUSIP number. The company stated that the reverse split was intended to align its number of shares outstanding with companies of similar size and scope, make the stock more attractive to certain institutional shareholders, and reduce expenditures associated with its annual meeting of stockholders.

In its financial communications, Tilray presents results across cannabis, beverage, wellness, and distribution segments and uses both GAAP and non-GAAP measures such as adjusted gross profit, adjusted gross margin, adjusted EBITDA, adjusted net income (loss), free cash flow, and net (debt) cash. The company explains that these non-GAAP measures are intended to provide additional insight into operational trends and period-over-period comparisons, while cautioning that they should not be viewed as substitutes for GAAP metrics.

Product and Category Highlights

Tilray’s news releases provide detailed examples of its product categories. In beverages, the company showcases:

• Premium spirits under the Breckenridge brand, including whiskeys and specialty finishes.
• Ready-to-drink cocktails from brands such as 10 Barrel Brewing and Cruisies.
• Craft beers from regional breweries including Blue Point Brewing, Montauk Brewing, SweetWater Brewing, Terrapin Beer Co., Atwater Brewery, Breckenridge Brewery, Hop Valley Brewing, and Widmer Brothers.
• Non-alcoholic offerings such as Runner’s High non-alcoholic beer, Montauk N.A. Golden, and Mock One zero-proof spirits.
• Hemp-derived THC beverages under brands like Happy Flower and Fizzy Jane’s.

In cannabis and wellness, Tilray’s communications highlight:

• Good Supply pre-rolls, flower, vapes, and concentrates, including 510-thread cartridges in strains such as Pineapple Express and Blue Dream.
• Redecan products, including Redees pre-rolls and Amped Live Resin Liquid Diamond vape cartridges that combine live resin and liquid diamonds.
• Broken Coast craft cannabis flower.
• Mollo cannabis-infused seltzers and beverages, including various THC and CBG combinations.
• XMG beverages and edibles, including Atomic Sours and XMG Zero sugar-free drinks.
• Chowie cannabis-infused chocolates.

Corporate Governance and Shareholder Matters

Tilray’s definitive proxy statement describes a classified board of directors divided into three classes, with directors standing for election on a staggered basis. At its 2025 annual meeting of stockholders, the company presented proposals including the election of a Class I director, ratification of its independent registered public accounting firm, an advisory vote on executive compensation, and governance changes to declassify the board and modify director removal provisions. Voting results disclosed in an 8-K show that the director election and auditor ratification were approved, the advisory compensation resolution received majority support, and the governance proposal did not receive sufficient votes to pass.

The proxy materials also describe the company’s use of a virtual annual meeting format via live webcast, allowing stockholders to vote and submit questions online. Tilray notes that its common stock is its only class of voting securities and that a specified portion of outstanding shares is required to constitute a quorum at the annual meeting.

Position in the Cannabis and Consumer Packaged Goods Landscape

Across its public statements, Tilray characterizes itself as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, with an emphasis on elevating lives through “moments of connection.” Its brand and product strategy centers on lifestyle positioning, mindful consumption trends, and the integration of cannabis and hemp-derived ingredients into beverages and other consumer categories. The company’s disclosures emphasize its multi-category platform, international footprint, and focus on regulated medical cannabis markets as key elements of its business model.